Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Dexamethasone in Adolescent Idiopathic Scoliosis
NCT05561725Phase 4Completed
- Sponsor
- Emory University
- Start
- Jan 2023
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in adolescent idiopathic scoliosis (AIS) comparing Standard of Care: Control with Dexamethasone (2 arms). Primary endpoints: C-Reactive Protein and Interleukin-6. Started Jan 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT05561725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05561725.